Maryland

The Prescription Drug Affordability Board (PDAB) has selected 6 drugs they propose to subject to a cost review process. If members wish to submit comments on any or all the choices, please send them to comments.pdab@maryland.gov with the subject line: Board Selected Drugs (Drug Name) by July 22. For more information on the PDAB or on the comment process, see the PDAB’s Board Selected Drugs Page.

Also in Maryland, Medicaid Fee-For-Service released Advisory #263 in reference to the Generic vs. Brand Status on Medicaid’s Preferred Drug List (PDL) effective July 1, 2024.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2024-06-27T11:02:03-04:00June 27, 2024|Maryland|

Minnesota

The Department of Health’s Rx Transparency team recently sent an email to pharmacies and other reporting entities providing further instructions for filing prescription drug pricing information that will be required later this year under law. Additionally, the email reminded pharmacies licensed in Minnesota that they are required to register an account with the Department of Health’s (MDH) Online Reporting Portal and report on the Public Interest Drug lists, stating that “pharmacies that have not yet registered should do so promptly and may use our Registration Quick-Start Guide (PDF) to get started.” For more information, visit: MN Rx Transparency Home Page, Information for Reporting Entities and Public Interest Drug Lists.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2024-06-27T11:00:37-04:00June 27, 2024|Minnesota|

Mississippi

On July 1, the Mississippi Division of Medicaid (DOM) will implement a single Pharmacy Benefit Administrator (PBA) to streamline and enhance the processing and management of pharmacy claims for all Medicaid members, including those enrolled in MississippiCAN and CHIP.

Operated by Gainwell Technologies, the PBA will also assume all pharmacy prior authorization responsibilities for drugs submitted on pharmacy claims. DOM will continue to require the use of the Universal Preferred Drug List (PDL). This decision comes after careful consideration and evaluation of various factors aimed at enhancing efficiency and transparency in the Medicaid delivery system.

Medicaid members should notice no disruption in their care if providers are prepared for this change.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2024-06-27T10:59:52-04:00June 27, 2024|Mississippi|

Missouri

NACDS sent a letter to Gov. Mike Parson (R) urging him to sign SB 751, legislation expanding the opportunity for pharmacies to participate in the 340B drug program. The bill also prohibits pharmaceutical manufacturers from restricting where patients can access their 340B medications, a restriction not in place before the pandemic. The Governor has until July 14 to act on the bill.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2024-06-27T10:59:20-04:00June 27, 2024|Missouri|

Nebraska

The Department of Health and Human Services announced the launch of a new feature on the State Immunization Information System (NESIIS). Beginning June 10, 2024, Nebraskans have the option to securely download their personal (or their child’s) immunization information from NESIIS to their Android or iOS mobile device. This enables the option to share immunization records from NESIIS quickly and easily with healthcare providers, schools or other organizations.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2024-06-27T10:58:40-04:00June 27, 2024|Nebraska|

New York

The State Department of Health released a notice of reminders to pharmacy providers in case of severe weather events.  These include drug storage, vaccines for children, drug delivery and NYRx prior authorizations.

For more information, please contact NACDS’ Ben Pearlman at 617-515-2603.

2024-06-27T10:58:12-04:00June 27, 2024|New York|

Ohio

Ohio will soon join the ranks of states that have updated its immunization law post-pandemic. On June 26, the last day of session prior to summer recess, the House passed, and the Senate concurred on SB 144. The bill will permit pharmacists and technicians to administer a vaccine “for any disease” to patients aged five years and older. It is now on its way to Gov. Mike DeWine (R) for signing. NACDS thanks our in-state partners, members and allies for the remarkable team effort in getting this bill across the finish line.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2024-06-27T10:57:11-04:00June 27, 2024|Ohio|

© National Association of Chain Drug Stores
All Rights Reserved | Privacy & Disclaimer

Go to Top